Advertisement
News
Subscribe to MDT Magazine News

Generex lands $3M, expands breast cancer vaccine study

January 25, 2011 10:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Generex Biotechnology Corp., a Worcester drug delivery-focused firm, is taking in at least $3 million in an investor offering, in addition to a plan to increase enrollment in a Phase 2 clinical study of a breast cancer vaccine.

EpiVax nets NIH grant for flu vaccine

January 25, 2011 10:36 am | by Mass High Tech: The Journal of New England Technology | Comments

EpiVax Inc., a Providence, R.I.-based developer of therapeutics for cancer and autoimmune diseases, has attracted a $458,000 grant from the National Institute of Allergy and Infectious Diseases to develop a universal influenza vaccine.

Genzyme voluntarily repays $6M in MLSC incentives

January 25, 2011 10:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Genzyme Corp. has voluntarily re-paid $6 million to Massachusetts that the company had received as a job creation incentive, after failing to meet the terms of the incentive by selling off one of its business units, said the CEO of the Massachusetts Life Sciences Center, Susan Windham-Bannister.

Advertisement

Crane Aerospace & Electronics and Cochlear Limited Sign another 5 Year Contract

January 25, 2011 9:01 am | by Crane Aerospace & Electronics | Comments

Redmond, Wash. – January 17, 2011 – Crane Aerospace & Electronics, Crane Electronics, Inc., Microelectronics Solutions, a segment of Crane Co. (NYSE: CR), signed another five year contract with Cochlear Limited.

Reportlinker Adds Brand Erosion Post-Patent Expiry - An analysis of small molecule brand erosion post-patent expiry

January 25, 2011 8:36 am | by Bio-Medicine.Org | Comments

NEW YORK, Jan. 25, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Brand Erosion Post-Patent Expiry – An analysis of small molecule brand erosion post-patent expiry...

TOPICS:

Reportlinker Adds The Top 10 CMOs in China

January 25, 2011 8:36 am | by Bio-Medicine.Org | Comments

NEW YORK, Jan. 25, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: The Top 10 CMOs in China http://www.reportlinker.com/p0363587/The-Top-10-CMOs-in-China.html IntroductionThis report discusses market dynamics, drivers, resistors and...

TOPICS:

Reportlinker Adds The Drug Discovery Outsourcing Market

January 25, 2011 8:35 am | by Bio-Medicine.Org | Comments

NEW YORK, Jan. 25, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: The Drug Discovery Outsourcing Market http://www.reportlinker.com/p0363588/The-Drug-Discovery-Outsourcing-Market.html Introduction This report investigates current trends...

TOPICS:

The American Association for Cancer Research Hosts its 102nd Annual Meeting

January 25, 2011 8:32 am | by AACR | Comments

The deadline for media housing requests for the AACR 102nd Annual Meeting 2011 is Friday, Feb. 25. A limited number of rooms have been set aside for editors and reporters, and we cannot guarantee that housing will be available after that date.

TOPICS:
Advertisement

Reportlinker Adds The 2011 Japanese Blood Banking Market

January 25, 2011 7:32 am | by Bio-Medicine.Org | Comments

NEW YORK, Jan. 25, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: The 2011 Japanese Blood Banking Market http://www.reportlinker.com/p0365340/The-2011-Japanese-Blood-Banking-Market.html This report presents a comprehensive analysis of...

TOPICS:

Reportlinker Adds The 2011 Blood Banking Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers

January 25, 2011 7:31 am | by Bio-Medicine.Org | Comments

NEW YORK, Jan. 25, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: The 2011 Blood Banking Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers...

TOPICS:

Summary Information for: LifeStent and LifeStent XL Vascular Stent

January 25, 2011 7:30 am | by U.S. Food & Drug Administration | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for LifeStent and LifeStent XL Vascular Stent (P070014S010).

TOPICS:

Reportlinker Adds The Drug Delivery Device Market Outlook to 2015

January 25, 2011 6:35 am | by Bio-Medicine.Org | Comments

NEW YORK, Jan. 25, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: The Drug Delivery Device Market Outlook to 2015 http://www.reportlinker.com/p0363596/The-Drug-Delivery-Device-Market-Outlook-to-2015.html Drug delivery device...

TOPICS:

If Hospitals Want a Competitive Advantage - Use Brain Monitors in Surgeries Requiring Sedation says Renowned Anesthesiologist

January 25, 2011 6:33 am | by Bio-Medicine.Org | Comments

NEWPORT BEACH, Calif., Jan. 25, 2011 /- Every business needs a competitive advantage over its rivals. Some use a cost advantage; others use a differentiation advantage. Hospitals are not immune from the constant struggle to attract and retain patients and doctors. Dr. Barry Friedberg says...

TOPICS:

R & J Public Relations Named Agency of Record for Aerocrine, Inc.

January 25, 2011 6:33 am | by Bio-Medicine.Org | Comments

BRIDGEWATER, N.J., Jan. 25, 2011 /- Aerocrine, Inc., an innovative medical technology company focused on the treatment of patients with inflamed airways, has selected R&J Public Relations, LLC of Bridgewater, N.J., as its public relations agency of record.  R&J will conduct...

TOPICS:

Reportlinker Adds The 2011 Clinical Chemistry Market: US, Europe, Japan

January 25, 2011 6:33 am | by Bio-Medicine.Org | Comments

NEW YORK, Jan. 25, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: The 2011 Clinical Chemistry Market: US, Europe, Japan http://www.reportlinker.com/p0365400/The-2011-Clinical-Chemistry-Market-US-Europe-Japan.html During the next decade,...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading